XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net loss from continuing operations $ (7,716) $ (23,098) $ (10,358)
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Depreciation and amortization 31,753 34,760 42,672
Impairment of long-lived assets and capitalized software 0 1,305 1,013
Amortization of debt issuance costs 1,391 624 0
Loss on disposals of fixed assets 126 263 12
Gain on sale of DXP Business (2,549) 0 0
Gain on disposals of intangible assets 0 (550) (3,477)
Amortization of debt discount 88 9 0
Deferred income taxes (164) 463 (911)
Stock-based compensation 5,461 9,343 11,137
Contingent consideration obligation 3,638 0 0
Operating lease impairment, net 175 1,353 5,350
Changes in operating assets and liabilities:      
Accounts receivable, net 14 (748) 11,703
Prepaid expenses and other current assets 6,954 (4,394) (1,641)
Accounts payable 3,024 (2,031) (7,127)
Accrued expenses (8,430) 3,468 898
Deferred revenues (8,312) (21,972) (43,200)
Other liabilities (8,094) 6,150 (6,635)
Net cash provided by (used in) operating activities 17,359 4,945 (564)
Investing activities:      
Purchases of fixed assets (1,408) (1,521) (885)
Additions to capitalized software (19,758) (22,972) (16,665)
Acquisition of intangible assets 0 0 (400)
Proceeds from the sale of intangibles 0 550 3,600
Proceeds from the sale of DXP Business 8,000 0 0
Maturity of marketable securities available for sale 0 0 11
Net cash used in investing activities (13,166) (23,943) (14,339)
Financing activities:      
Share-based compensation-related proceeds, net of taxes paid on withholding shares  0 (1) 0
Taxes paid on withholding shares (83) (1) (9)
Debt issuance costs related to long term debt 0 (8,606) 0
Proceeds from issuance of long term debt 0 141,077 0
Borrowings on revolving line of credit 0 0 10,000
Repayment of revolving line of credit 0 (10,000) 0
Proceeds from issuance of common stock 0 110,000 0
Proceeds from issuance of Series B Preferred stock 0 75,000 0
Net cash (used in) provided by financing activities (13,276) 16,188 9,991
Effect of exchange rate changes on cash (500) 643 (418)
Net decrease in cash and cash equivalents (9,583) (2,167) (5,330)
Cash and cash equivalents, beginning of period 31,504 33,671 39,001
Cash and cash equivalents, end of period 21,921 31,504 33,671
Supplemental disclosures of cash flow information:      
Cash paid for income taxes 4,562 3,449 6,138
Cash refund for income taxes 5,206 420 15,585
Cash paid for interest 11,822 3,657 212
Series B Preferred Stock      
Financing activities:      
Stock issuance costs 0 (2,495) 0
Preferred dividend paid in cash (6,455) (1,781) 0
Redemption of Preferred stock (6,738) 0 0
Supplemental disclosures of non-cash investing and financing activities:      
Paid in kind dividends on Preferred stock 2,581 0 0
Series A Preferred Stock      
Financing activities:      
Redemption of Preferred stock 0 (278,665) 0
Supplemental disclosures of non-cash investing and financing activities:      
Paid in kind dividends on Preferred stock [1] 0 31,277 36,776
Common Stock      
Financing activities:      
Stock issuance costs $ 0 $ (8,340) $ 0
[1] 2021 amounts include amortization of preferred stock issuance costs accelerated due to Series A redemption.